----
Current ValuationThe current P/E ratio is 24.08, above the reasonable range, cheaper than 6.51% of the time in the past 3 years, and the industry ranks 13/74, the industry Median --.
24.08xP/E
$230.81Stock price
$9.59Earnings per share
24.08xP/E
Stock price$230.81Earnings per share$9.59
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 20.96x
- Typical range
- 19.04x–22.10x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
07142128
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
CVSUSCVS Health | 22.96x | 394.45% | $112.29B |
LHUSLabcorp | 25.42x | 33.20% | $25.48B |
DGXUSQuest Diagnostics | 24.08x | 16.18% | $25.48B |
CHEUSChemed | 26.48x | 26.94% | $7.28B |
OPCHUSOption Care Health | 22.19x | 18.20% | $4.65B |
ADUSUSAddus Homecare | 20.26x | 18.27% | $2.13B |
VMDUSViemed Healthcare | 24.72x | 11.71% | $358.41M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
